Gender Male
Hermann Haller, M.D., became the institution’s second fulltime president in July 2018, succeeding Kevin Strange, Ph.D., who oversaw a significant expansion of the institution’s research and educational programs during his nine-year tenure.
Haller received his medical degree from the Free University of Berlin and completed his postdoctoral work at
Yale University. He has published more than 700 peer-reviewed articles, holds six world-wide patents and has founded four biotech companies. He has received many honors and awards and serves on numerous advisory boards, including those of Bayer, Boehringer Ingelheim, Genzyme and Novo Nordisk. In addition to his position at the MDI Biological Laboratory, he is also a full professor and chairman of the Division of Nephrology at the Hannover Medical School in Germany.
